Since its introduction in the hospital in 2020, Cleveland Clinic Abu Dhabi (CCAD) has achieved a significant milestone. It is part of the M42 network and has successfully completed 50 deep brain stimulation implants. Being one of the leading hospitals in the UAE to provide this unique treatment option to Parkinson’s disease patients, CCAD reaffirms its commitment. The commitment is to pioneering innovative solutions and advancing medical technology in the UAE and the wider region.
Deep brain stimulation involves a sophisticated surgical procedure. In this procedure, electrodes are implanted in specific areas of the brain. These electrodes deliver controlled electrical impulses to modify abnormal brain activity responsible for Parkinson’s disease symptoms. A device, known as an implantable pulse generator (IPG), connects electrodes. This device is placed beneath the skin on the chest. Once activated, the IPG emits continuous electrical pulses to the targeted areas of the brain, effectively modulating abnormal neural activity and reducing the debilitating symptoms associated with Parkinson’s disease.
Dr. Florian Roser, Chair of the Neurological Institute at CCAD, stated, “In the realm of Parkinson’s disease treatment, the advent of deep brain stimulation stands as a revolutionary beacon of hope. This groundbreaking procedure not only alleviates symptoms but fundamentally transforms the lives of patients, offering newfound possibilities and restoring a sense of control in the face of this daunting neurological challenge. As a provider of deep brain stimulation in the UAE, we take pride in offering cutting-edge treatments, reaffirming our dedication to elevating the standard of care for Parkinson’s patients.”
As a destination for world-class complex care, CCAD’s offering of deep brain stimulation surgery has revolutionized patient care in the UAE. This has significantly reduced the need for patients to travel abroad for specialized treatment. In fact, patients traveling from the region and beyond seek treatment at the hospital due to the availability of this cutting-edge technology.
Three years ago, CCAD initiated the journey toward this remarkable achievement by collaborating with Cleveland Clinic in the U.S. They introduced deep brain stimulation surgery for UAE patients. Dr. Shivam Om Mittal, Staff Physician in the Neurological Institute, and Dr. Tanmoy K. Maiti, Associate Staff Physician and expert functional neurosurgeon at Cleveland Clinic Abu Dhabi, led the surgeries. The patient-centric multidisciplinary approach, involving a team of nurses, physical therapists, speech therapists, and more, ensures the best patient outcome. The team’s collaborative discussions and consultations aim to provide patients with comprehensive care and support throughout their treatment journey.
Dr. Mittal explained the qualification of patients for deep brain stimulation surgeries. “The procedure is for people whose Parkinson’s symptoms are really affecting their daily life, despite being prescribed the best medication. These symptoms might include shaking, stiffness, or trouble moving. It makes regular activities challenging, despite taking medication. Additionally, for deep brain stimulation, being physically strong for surgery is crucial. Being prepared for the necessary care afterwards is also vital. For those who can’t have deep brain stimulation, other treatment options are available such as pump therapy which is also routinely done at Cleveland Clinic Abu Dhabi,” he said.
Dr. Maiti added, “Every surgery performed has proceeded seamlessly, devoid of complications. We’re thrilled to share that our patients are not just content but experiencing life-changing transformations. In fact, one of our patients once told me he wished he had done this earlier because it has changed the quality of his life.”
Also Read: Cleveland Clinic Abu Dhabi Performs Region’s First Robotic VTOS Surgery
Most commonly, Parkinson’s disease manifests as slowness in movements, shaking of the hand (tremor), and muscle stiffness. The prevalence of the disease is rising rapidly, making it the fastest-growing neurological condition globally. According to the World Health Organization, the prevalence of Parkinson’s disease has doubled in the past 25 years. Global estimates showed over 8.5 million individuals with the disease in 2019. Parkinson’s disease is a progressive condition, and regular follow-up appointments are essential to maintain optimal symptom control. CCAD provides specialized treatment. This includes programming adjustments. It also involves a multidisciplinary approach to ensure that patients continue to experience the benefits of deep brain stimulation.
